Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA062444-02
Application #
2103680
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1995-04-01
Project End
1999-01-31
Budget Start
1996-02-01
Budget End
1997-01-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Josefsson, Anders; Nedrow, Jessie R; Park, Sunju et al. (2016) Imaging, Biodistribution, and Dosimetry of Radionuclide-Labeled PD-L1 Antibody in an Immunocompetent Mouse Model of Breast Cancer. Cancer Res 76:472-9
Song, Hong; Hedayati, Mohammad; Hobbs, Robert F et al. (2013) Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody. Mol Cancer Ther 12:2043-54
Sgouros, George; Frey, Eric; Wahl, Richard et al. (2008) Three-dimensional imaging-based radiobiological dosimetry. Semin Nucl Med 38:321-34
Sgouros, George (2005) Dosimetry of internal emitters. J Nucl Med 46 Suppl 1:18S-27S
Emfietzoglou, Dimitris; Kostarelos, Kostas; Papakostas, Alexandros et al. (2005) Liposome-mediated radiotherapeutics within avascular tumor spheroids: comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibody. J Nucl Med 46:89-97
Kostarelos, Kostas; Emfietzoglou, Dimitris; Papakostas, Alexandros et al. (2004) Binding and interstitial penetration of liposomes within avascular tumor spheroids. Int J Cancer 112:713-21
Sgouros, George; Kolbert, Katherine S; Sheikh, Arif et al. (2004) Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med 45:1366-72
Ballangrud, Ase M; Yang, Wei-Hong; Palm, Stig et al. (2004) Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression. Clin Cancer Res 10:4489-97
Sgouros, George; Squeri, Shannon; Ballangrud, Ase M et al. (2003) Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response. J Nucl Med 44:260-8
Palm, Stig; Enmon Jr, Richard M; Matei, Cornelia et al. (2003) Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI. J Nucl Med 44:1148-55

Showing the most recent 10 out of 27 publications